Business Standard

Parmax Pharma Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for To Approve The Audited Financial Statements For The Quarter And Year Ended On 31.03.2024. Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More20/05/2024
Appointment of Company Secretary and Compliance Officer Meeting of the Board of Directors of Parmax Pharma Limited held on 2nd May 2024 ...Read More02/05/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More29/04/2024
CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER SEBI REGULATION 40(9) CERTIFICATE REQUIRED FOR THE COMPLIANCE OF REGULATION 40(9) / (10) OF SEBI (LODR...Read More29/04/2024
Compliance Certificate Pursuant To Regulation 7(3) Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation a...Read More12/04/2024
Compliance Certificate Pursuant To Regulation 7(3) Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation a...Read More12/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 certificate under regulation 74(5) SEBI (Depositories and Participants) regulati...Read More07/04/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding loss of share certificates02/04/2024
Closure of Trading Window Closure of trading window28/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss share certificates20/02/2024
Board Meeting Outcome for Financial Results For Quarter And Nine Months Ended 31.12.2023 Financial results for quarter and nine months ended 31.12.202314/02/2024
Financial Results For Quarter And Nine Months Ended 31.12.2023 Financial statements for quarter and nine months ended on 31.12.202314/02/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimationm of loss of share certificate07/02/2024
Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results For Quarter Ended 31St Deccember 2023. Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More07/02/2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Intimation for resignation of Company Secretary and Compliance officer.31/01/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP)Regulations 2018 for quarter ende...Read More13/01/2024
Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More07/08/2023
Shareholder Meeting / Postal Ballot-Scrutinizers Report Voting results under Regulation 44(3) of SEBI (Listing Obligation and Disclosure...Read More21/07/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regul...Read More10/07/2023
Closure of Trading Window Closure of Trading window29/06/2023

Load more